Management of Seronegative Rheumatoid Arthritis

Assessment and Diagnosis

Seronegative RA may represent a diagnostic challenge, and the possibility of misdiagnosis or coexistent mimicking disease should be considered, according to the European League Against Rheumatism 1, 2
Ultrasonography may be considered to confirm the presence of inflammatory activity when there is doubt based on clinical assessment, as recommended by the European League Against Rheumatism 2

Seronegative status may influence treatment response; patients who are seronegative for rheumatoid factor may respond better to abatacept or tocilizumab rather than rituximab, as suggested by the American College of Rheumatology 3
Consider triple DMARD therapy with methotrexate, sulfasalazine, and another agent (excluding hydroxychloroquine) for patients with moderate to high disease activity, as recommended by the American College of Rheumatology 3, 5
Methotrexate (15-25 mg/week as tolerated) can be used as the cornerstone therapy, with the addition of sulfasalazine as part of combination therapy, according to the American College of Rheumatology 5, 6
Biologic agents, such as TNF inhibitors, abatacept, or tocilizumab, can be considered if disease activity remains high despite conventional DMARDs, as recommended by the American College of Rheumatology 3, 5

Uncontrolled diabetes may be exacerbated by certain RA medications, particularly glucocorticoids, and should be monitored closely, as advised by the European Society of Cardiology 4
Low-dose prednisone (≤10 mg/day) may be used cautiously if needed for disease control, with careful monitoring of glucose levels, according to the European Society of Cardiology 4
Exercise interventions can improve both RA symptoms and glycemic control, as recommended by the American College of Sports Medicine 8

Reassess disease activity after 3-6 months of new treatment, and monitor for development of any new adverse reactions to alternative therapies, as recommended by the American College of Rheumatology 3, 7
Consider ultrasonography to assess inflammatory activity if clinical assessment is challenging, according to the European League Against Rheumatism 1, 2
Consistent engagement in exercise is strongly recommended for RA management, as advised by the American College of Sports Medicine 8